Development and Validation of a Multivariable Exercise Adherence Prediction Model for Patients with COPD: A Prospective Cohort Study
DOI: https://doi.org/10.2147/COPD.S401023
2023-03-23
International Journal of COPD
Abstract:Ellen Ricke, 1 Eric W Bakker 2 1 Department of Social Psychology, University of Groningen, Groningen, the Netherlands; 2 Department of Epidemiology and Data Science | Division EBM, Academic Medical Centre, Amsterdam, the Netherlands Correspondence: Ellen Ricke, Department of Social Psychology, University of Groningen, Grote Kruisstraat 2/1, Groningen, 9712 TS, the Netherlands, Tel +31 6 211 817 02, Email Purpose: Pulmonary rehabilitation (PR) is considered a cost-effective method of improving health-related quality of life in patients with chronic obstructive pulmonary disease (COPD). However, increasing demand and increasing costs of supply demands for sustainable and affordable care. One of the possible solutions to keep care affordable is self-management. A challenge here is non-adherence. Understanding who are adherent and who are non-adherent could be helpful to differentiate between patients who need more or less support. Therefore, the aim of this study was to develop and validate a model to predict adherence to PR in patients with COPD. Patients and methods: A multivariable logistic regression model for exercise adherence was developed. Eight candidate predictors, that were prespecified, were obtained in a prospective cohort study from 196 patients with COPD following PR in 53 primary physiotherapy practices in the Netherlands and Belgium, between January 2021 and August 2022. To create a parsimonious model, variable selection using backward selection was performed with a p -value of > 0.05 for elimination. Model performance was assessed by discrimination, calibration and clinical utility. Internal validation was assessed by bootstrapping (n = 500). Results: The final model included four predictors: intention, depression, MRC-score and alliance. The optimism-corrected AUC after bootstrap internal validation was 0.79 (95% CI, 0.72– 0.85). Calibration plots suggested good calibration and decision curve analysis showed great net benefit in a wide range of risk thresholds. Conclusion: The exercise adherence prediction model has potential for clinical utility to predict adherence in patients with COPD. Information from such a model can be used to manage the patient instead of managing the disease, and thereby to determine the treatment frequency for each individual patient. As a result, healthcare capacity might be better distributed, potentially reducing pressure on healthcare without compromising the effectiveness of PR for the individual patient. Keywords: chronic obstructive pulmonary disease, sustainable healthcare, pulmonary rehabilitation, self-management Nowadays, people are getting older, but also face more chronic diseases as a result. Chronic obstructive pulmonary disease, COPD, is one of the most common chronic diseases. Unfortunately, COPD cannot be cured, so people with COPD need a lot of care. In addition to medical treatment, supervised exercise is an effective treatment to manage COPD. But with the increase in the number of people with COPD, and other chronic diseases, care is becoming increasingly expensive and there is a shortage of healthcare providers to support patients. Both people with COPD and healthcare providers would benefit if patients could take more control of their own health. This self-management does require that patients keep the agreements they made with their healthcare provider. But this is not always easy for everyone. With this study, we examined whether certain people might need more support from a healthcare provider than other people. People who participated in our study, and who suffered more from the following symptoms or problems, need more support from a healthcare provider: People who do not have these symptoms or problems, or very few, have less difficulty with following the agreements. These people might exercise more independently with regular follow-up. By discussing this together, more personalized care might be given. Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide with an economic and social burden that is both substantial and increasing. 1 The prevalence of COPD increased by almost 40% between 1990 and 2017, and by 2017 COPD had become the third leading cause of death globally. 2 In the European Union, the total costs of respiratory disease are estimated to be about 6% of the total annual healthcare budget, with COPD accounting for 56% (38.6 billion euros). 3 In the United States, the costs attributable to COPD are expected to increase over the next 20 years, with projected costs of 800.90 billion dollars. 4 COPD prevalence, morbidity and mortality vary across countries. 5 Based on demographic trends, the absol -Abstract Truncated-
English Else